AS ONE : Supplementary materials for Summary of Financial Results for the 3rd quarter 2022
January 31, 2022 at 02:29 am EST
Share
January 31st,2022
(Security code:T7476)
The 3rd quarter Results for FYE March 2022
3Q for FYE March 2021
3Q for FYE March 2022
Amount
Ratio
Initial plan
Amount
Ratio
YoY
(JPYmn)
(JPYmn)
Net sales
56,744
-
61,505
61,779
-
+8.9
%
Gross profit
18,056
31.8
%
18,155
18,044
29.2
%
(0.1)
%
SG&A expenses
11,542
20.3
%
11,982
11,797
19.1
%
+2.2
%
Operating profit
6,513
11.5
%
6,173
6,246
10.1
%
(4.1)
%
Ordinary profit
6,795
12.0
%
6,378
6,439
10.4
%
(5.2)
%
Profit
3,556
6.3
%
4,505
4,597
7.4
%
+29.3
%
(JPYmn)
※(
)YoY
(JPYmn)
61,779
Net sales
[
+8.9%
+5,035 ]
Ⅰ.Division
[1]Research and Industrial Instruments Division
① Scientific Sector
②Industrial Sector
[2]Medical Instruments Division
[3]Others[Fees for T21 system use ]
48,259
[
+13.7%
+5,797
]
35,922
[
+14.1%
+4,428
]
12,336
[
+12.5%
+1,369
]
13,147
[
(6.0)%
(832)
]
373
[
+22.8%
+69
]
Ⅱ.Medium-term Management Plan
17,865
[
+27.9%
+3,898
]
[1]E-commerce
14,545
[
+28.1%
+3,192
]
① Consolidated Purchasing
7,393
[
+31.7%
+1,780
]
②Wave
278
[
+189.5%
+182
]
③AXEL
1,391
[
+9.6%
+121
]
④E-commerce companies
5,482
[
+25.3%
+1,108
]
[2]Overseas
3,320
[
+27.0%
+706
]
① China
2,229
[
+21.5%
+394
]
②Other Overseas
1,091
[
+40.0%
+311
]
1 / 2
Gross profit
18,044
[
(0.1)%
(12)
]
Gross profit margin
29.2
%
[
(2.6) p ]
Main reasons for increase and decrease
Infection prevention products were profitable in FYE03 / '21, but some of
these were reduced in profit to FYE03 / '22. Gross margin declined as a
result of these inventory prices being written down in the 2nd quarter.
However, due to the decrease or elimination of unprofitable inventories,
the gross profit margin returned to 30% in the 3rd quarter(Oct. to Dec.),
and profitability is on a recovery trend.
11,797
SG&A Expenses
[
+2.2%
+254
]
Main reasons for increase and decrease
(1)Freight & warehouse cost
3,385
[
+14.9%
+438
]
(2)Personnel expenses
4,121
[
+4.7%
+185
]
(3)Real estate rental expenses
988
[
(2.7)%
(27)
]
(4)Depreciation
734
[
(1.4)%
(10)
]
Complementary information
1
Net sales:Increased in income consecutive for 12 years and Recorded high for the past 11 consecutive fiscal years
Profit:Eliminated the extraordinary loss of 1.2 billion yen on FYE03 / 2021 and increased profits by 29.3%. Recorded high for the 1st time in 2 years.2
Medium-term Management Plan:Sales of 2 Growth Targets: vs plan +6.5%
E-commerce sales: vs plan +6.5%
Overseas sales: vs plan +6.3%
2 / 2
Attachments
Original Link
Original Document
Permalink
Disclaimer
As One Corporation published this content on 31 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 January 2022 07:27:58 UTC.
As One Corp is a Japan-based company principally engaged in the sale of scientific equipment and apparatus for various laboratories, research institutes, production facilities and medical facilities. The research and industrial equipment business is engaged in the wholesale of equipment and apparatus, which is used by researchers and technicians, to scientific equipment dealers. This business is also engaged in the provision of product catalogs to dealers, as well as the import and sale of physics and chemistry equipment. The hospital and nursing care business is engaged in the wholesale of equipment and apparatus, which is used by nursing care-related persons, to medical and nursing care institutions. The other business provides purchasing business proxy service using a web system, and to receive the system usage fee by the final user who participates in the system.